Jubilant Ingrevia Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Jubilant Ingrevia Ltd is ₹ 584.7 as of 20 Mar 15:30 . The P/E Ratio of Jubilant Ingrevia Ltd changed from 76.6 on March 2021 to 40.9 on March 2025 . This represents a CAGR of -11.79% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Jubilant Ingrevia Ltd changed from ₹ 4158 crore on March 2021 to ₹ 10350 crore on March 2025 . This represents a CAGR of 20.01% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 1060 crore as compare to the Sep '25 revenue of ₹ 1131 crore. This represent the decline of -6.29% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 122.91 crore as compare to the Sep '25 ebitda of ₹ 146.25 crore. This represent the decline of -15.96% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Jubilant Ingrevia Ltd changed from ₹ 48.74 crore to ₹ 46.9 crore over 7 quarters. This represents a CAGR of -2.17% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Jubilant Ingrevia Ltd changed from 14.45 % on March 2021 to 30.24 % on March 2025 . This represents a CAGR of 15.92% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Jubilant Ingrevia Ltd

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh.
The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Jubilant Ingrevia Ltd or Saroja Pharma Industries India Ltd?

Market cap of Jubilant Ingrevia Ltd is 9,313 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Jubilant Ingrevia Ltd stock price is INR ₹584.7. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Jubilant Ingrevia Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.